Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma.

ABSTRACT:

Objective

Patients with hematological malignancies have an elevated risk of developing pneumonia after contracting COVID-19. Lymphoma is the most prevalent hematologic malignancy. It is critical to identify patients at high risk of contracting COVID-19-associated pneumonia.

Methods

From January 11-31, 2023, we distributed questionnaires to patients diagnosed with lymphoma according to 2016 World Health Organization diagnostic and classification criteria. COVID-19 infection was confirmed based on symptoms and laboratory tests. Pneumonia was confirmed using computed tomography scans.

Results

In total, 257 patients were included in this study; 221 patients (86.0%) had COVID-19 infection and 61 (27.6%) of these had pneumonia. Patients with B-cell non-Hodgkin lymphoma (B-N

SUBMITTER: Liu D 

PROVIDER: S-EPMC11743689 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature